Yong‐Yu Yang

1.1k total citations
31 papers, 817 citations indexed

About

Yong‐Yu Yang is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Yong‐Yu Yang has authored 31 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Yong‐Yu Yang's work include Liver Disease Diagnosis and Treatment (4 papers), Ginseng Biological Effects and Applications (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Yong‐Yu Yang is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Ginseng Biological Effects and Applications (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Yong‐Yu Yang collaborates with scholars based in China, Taiwan and Macao. Yong‐Yu Yang's co-authors include Xi‐Ding Yang, Dongsheng Ouyang, Guoping Yang, Daxiong Xiang, Fen Li, Xi Xie, Siyi Jiang, Pingfei Fang, Yingjun Zhou and Chang‐Ping Hu and has published in prestigious journals such as Hepatology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yong‐Yu Yang

29 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong‐Yu Yang China 15 456 155 108 101 80 31 817
Xueyan Zhou China 16 494 1.1× 116 0.7× 74 0.7× 81 0.8× 76 0.9× 61 918
Minh Truong South Korea 18 494 1.1× 177 1.1× 133 1.2× 81 0.8× 53 0.7× 25 958
Xi‐Ding Yang China 11 360 0.8× 128 0.8× 88 0.8× 54 0.5× 61 0.8× 18 588
Mohamed A. Kandeil Egypt 16 304 0.7× 93 0.6× 110 1.0× 127 1.3× 67 0.8× 44 872
Lei Dong China 16 424 0.9× 141 0.9× 155 1.4× 216 2.1× 62 0.8× 42 1.0k
Xiaobao Gong China 17 349 0.8× 137 0.9× 77 0.7× 80 0.8× 45 0.6× 25 742
Xin Han China 20 460 1.0× 134 0.9× 96 0.9× 258 2.6× 73 0.9× 59 1.1k
Laddawan Senggunprai Thailand 21 617 1.4× 79 0.5× 172 1.6× 77 0.8× 65 0.8× 66 1.1k

Countries citing papers authored by Yong‐Yu Yang

Since Specialization
Citations

This map shows the geographic impact of Yong‐Yu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Yu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Yu Yang more than expected).

Fields of papers citing papers by Yong‐Yu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong‐Yu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Yu Yang. The network helps show where Yong‐Yu Yang may publish in the future.

Co-authorship network of co-authors of Yong‐Yu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yong‐Yu Yang. A scholar is included among the top collaborators of Yong‐Yu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong‐Yu Yang. Yong‐Yu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yong‐Yu, et al.. (2025). Manshenkang granules alleviate fibrosis in chronic renal failure rats by regulating the PDE4b/cAMP pathway. Journal of Ethnopharmacology. 344. 119506–119506. 1 indexed citations
2.
Wong, Susan, Yong‐Yu Yang, Hui Chen, et al.. (2025). New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024. Acta Pharmacologica Sinica. 46(5). 1145–1155. 1 indexed citations
3.
Xie, Li, Hui Chen, Li Zhang, et al.. (2025). Suppressing MASH fibrotic progression by blocking succinate-GPR91 signaling in HSCs. Hepatology. 83(4). 888–906. 1 indexed citations
4.
Ding, Jia, Yong‐Yu Yang, Pengtao Li, et al.. (2024). TGF-β1/SMAD3-driven GLI2 isoform expression contributes to aggressive phenotypes of hepatocellular carcinoma. Cancer Letters. 588. 216768–216768. 7 indexed citations
5.
Liang, Xiayi, Duo Wang, Xiaobo Wang, et al.. (2024). Tumor microenvironment-responsive manganese-based nano-modulator activate the cGAS-STING pathway to enhance innate immune system response. Journal of Nanobiotechnology. 22(1). 535–535. 19 indexed citations
6.
Xie, Li, et al.. (2024). Both liver parenchymal and non-parenchymal cells express JCAD protein under various circumstances. Clinical and Molecular Hepatology. 30(2). 279–280.
7.
Yang, Yong‐Yu, et al.. (2024). Hepatic artery pseudoaneurysm: three case reports and literature review. Frontiers in Medicine. 11. 1422895–1422895. 1 indexed citations
8.
Yang, Xi‐Ding, Lingfeng Yang, Jingjing Li, et al.. (2024). Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis. European Journal of Clinical Pharmacology. 80(8). 1181–1187. 3 indexed citations
9.
Yang, Yong‐Yu, et al.. (2023). Esculin ameliorates obesity-induced insulin resistance by improving adipose tissue remodeling and activating the IRS1/PI3K/AKT/GLUT4 pathway. Journal of Ethnopharmacology. 319(Pt 2). 117251–117251. 23 indexed citations
10.
Yang, Xi‐Ding, et al.. (2022). Potential lipolytic regulators derived from natural products as effective approaches to treat obesity. Frontiers in Endocrinology. 13. 1000739–1000739. 19 indexed citations
11.
Hao, Xinyan, Junyong Wu, Daxiong Xiang, & Yong‐Yu Yang. (2022). Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years. Frontiers in Pharmacology. 13. 846715–846715. 6 indexed citations
12.
Yang, Yong‐Yu, Li Xie, Ning‐Ping Zhang, et al.. (2022). Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis. Acta Pharmacologica Sinica. 43(5). 1180–1190. 36 indexed citations
13.
Yang, Xi‐Ding & Yong‐Yu Yang. (2022). Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications. Frontiers in Endocrinology. 13. 853822–853822. 84 indexed citations
14.
Peng, Weijun, et al.. (2022). Pharmacological Aspects of Natural Quercetin in Rheumatoid Arthritis. Drug Design Development and Therapy. Volume 16. 2043–2053. 44 indexed citations
15.
Xie, Xi, et al.. (2021). Ginsenoside compound K- a potential drug for rheumatoid arthritis. Pharmacological Research. 166. 105498–105498. 32 indexed citations
16.
Yang, Yong‐Yu, Ling Ye, Jing Chen, et al.. (2021). Dok3 is involved in cisplatin-induced acute kidney injury via regulation of inflammation and apoptosis. Biochemical and Biophysical Research Communications. 569. 132–138. 7 indexed citations
17.
Yang, Yong‐Yu, et al.. (2019). Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase. Molecular Medicine Reports. 19(3). 2245–2253. 53 indexed citations
18.
Yang, Xi‐Ding, Yong‐Yu Yang, Dongsheng Ouyang, & Guoping Yang. (2014). A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia. 100. 208–220. 218 indexed citations
19.
Yang, Yong‐Yu, Xi‐Ding Yang, Bing Xu, et al.. (2014). Chemical constituents of Morus alba L. and their inhibitory effect on 3T3-L1 preadipocyte proliferation and differentiation. Fitoterapia. 98. 222–227. 68 indexed citations
20.
Tsai, Eing‐Mei, et al.. (2005). Atrial natriuretic peptide inhibits ovarian functions in female mice. European Journal of Obstetrics & Gynecology and Reproductive Biology. 119(2). 215–218. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xueyan Zhou Breakdown of academic impact, for papers by Minh Truong Breakdown of academic impact, for papers by Xi‐Ding Yang Breakdown of academic impact, for papers by Mohamed A. Kandeil Breakdown of academic impact, for papers by Lei Dong Breakdown of academic impact, for papers by Xiaobao Gong Breakdown of academic impact, for papers by Xin Han Breakdown of academic impact, for papers by Laddawan Senggunprai
Rankless by CCL
2026